Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-35
Closed -$765 – 1194
2024
Q1
$765 Hold
35
– – ﹤0.01% 1006
2023
Q4
$814 Hold
35
– – ﹤0.01% 946
2023
Q3
$691 Hold
35
– – ﹤0.01% 953
2023
Q2
$794 Hold
35
– – ﹤0.01% 976
2023
Q1
$687 Hold
35
– – ﹤0.01% 981
2022
Q4
$602 Buy
+35
New +$621 ﹤0.01% 1061

Other funds holding RXO

Glen Eagle Advisors's RXO Position: Q2 2024 in Review

Glen Eagle Advisors sold out of RXO (RXO) in Q2 2024, closing a stake of 35 shares — an estimated $765 sold.

Glen Eagle Advisors first reported a position in RXO in Q4 2022 and held it in 6 quarters. The position peaked at $814 in Q4 2023. 243 funds tracked by Wall St. Rank hold RXO as of Q2 2024.

  • Glen Eagle Advisors reported no remaining RXO position as of Q2 2024 after selling out during the quarter.
  • Glen Eagle Advisors sold 35 RXO shares in Q2 2024, an estimated $765.
  • Glen Eagle Advisors first reported a position in RXO in Q4 2022 and held it in 6 quarters.
  • Glen Eagle Advisors's RXO position peaked at $814 in Q4 2023.
  • 243 funds tracked by Wall St. Rank held RXO as of Q2 2024.

Based on Glen Eagle Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.